The results clearly indicated that depletion of CD8+ T cells compromised the anti-tumor effect of LR-DPVB, while depletion of CD4+ T cells did not exert a significant impact on tumor progression (Supplementary Fig. 2g–h, Supplementary Fig. 3b–e). This evidence concerns the gene CD8A and neoplasm.